The FDA has approved suzetrigine, a groundbreaking painkiller that blocks sodium channels to provide opioid-level pain relief without the risks of addiction, sedation, or overdose. Known as Journavx, this drug is the first in over two decades to introduce a new pain relief mechanism. Clinical trials showed it matched opioids in effectiveness but with fewer side effect…
Related Posts
Samsung Galaxy S25 Slim May Not Be Sold Through US Carriers, Priced Between Galaxy S25 Plus and S25 Ultra
- staff
- January 20, 2025
- 0
Samsung Galaxy S25 Slim may not be launched in all global markets, according to claims by a tipster. The South Korean technology conglomerate is scheduled […]
Human Sense of Smell Detects Scent Changes Faster Than Previously Thought, Study Finds
A recent study led by Dr Wen Zhou from the Chinese Academy of Sciences reveals that humans can detect changes in smells much faster than […]
Qualcomm’s Savi Soin on “Made for India” Products, Strategy, and Enhancing User Experience
- staff
- March 5, 2025
- 0
Gadgets 360 spoke to Savi Soin, Senior Vice President and President of Qualcomm India about the many announcements Qualcomm India has made in the last […]